Back to top

Image: Bigstock

3 Dow Stocks to Buy Amid Tech Selloff

Read MoreHide Full Article

The Dow opened slightly higher on Wednesday morning as investors look to rebound from a brutal day of trading Tuesday that saw tech stocks drop en masse. With international trade fears cooled for now, the 30-stock Dow fared better during the selloff than the tech-heavy Nasdaq, suggesting that investors might be shifting their sector exposure to favor consumer staples and industrials right now.

Tech’s recent volatility seems to stem from a combination of profit taking and new skepticism surrounding internet privacy in the wake of Facebook’s latest data scandal. The famous “FANG” stocks—Facebook, Amazon (AMZN - Free Report) , Netflix (NFLX - Free Report) , and Alphabet (GOOGL - Free Report) —have been among the worst performers.

For those still bullish on tech, the selloff presents an interesting buying opportunity, especially with all signs pointing to another strong earnings season for the sector. However, some might be looking to move some cash out of the tech space and into lower-risk plays.

With this in mind, the Dow 30 stocks include plenty of attractive options today. Check out these three Dow stocks to buy now!

1.       The Travelers Companies, Inc. (TRV - Free Report)

This insurance giant has exposure to nearly all of the industry’s key markets, making it one of the largest and most well-known brands in the business. The company is also looking strong on the back of an improving earnings outlook and a solid financial position.

TRV’s full-year EPS estimates have trended higher recently, with our Zacks Consensus Estimate for the fiscal period gaining $1.00 over the past 90 days. This positive revision activity has earned the stock a Zacks Rank #2 (Buy). Meanwhile, the company continues to be a cash cow, bringing in about $26 in cash per share right now.

TRV uses its financial strength to reward shareholders and offers a dividend yield of 2.1%. Insurance might not be the most exciting industry, but investors might start flocking to cash-heavy income plays like TRV soon.

 

2.       Johnson & Johnson (JNJ - Free Report)

This healthcare and consumer goods is likely outside of the problem areas that investors should be most cautious about right now, and its improving earnings outlook and attractive valuation make it an appealing bet right now.

The Zacks Consensus Estimate for JNJ’s full-year earnings has gained 26 cents over the past 90 days, lifting the stock to a Zacks Rank #2 (Buy). JNJ is also trading at about 17x forward 12-month earnings, which represents its lowest earnings multiple over the past year. This company is also an income pick and offers a dividend yield of about 2.6%.

 

3.       The Boeing Company (BA - Free Report)

Boeing was sold off amid concerns that China would target the company for retaliation against Trump’s latest batch of tariffs, but reports that U.S. officials were negotiating with Chinese regulators should cool these fears. With that said, investors can now scoop up this Zacks Rank #1 (Strong Buy) stock at a discount.

Boeing owes its strong Zacks Rank to an improving earnings outlook, but the company is also well positioned to benefit from encouraging news. For instance, we recently learned that American Airlines (AAL) dropped its deal with Airbus, meaning that Boeing likely snagged a contract worth up to $8 billion.

Boeing has sunk nearly 12% over the past month, but if trade negotiations go well, the stock should rebound just fine.

 

Want more market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research. It's not the one you think.

See This Ticker Free >>